NPPB and diabetes mellitus: Medical researchers have discovered that biomarkers like B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) can be used to predict CVD in patients with DM, specifically heart failure.